Macroaxis: Personalized Investing
Simple Personalized Investing

GLV-B GLV-A NRG BQE Basic Utilities Junk Bonds Soft Drinks Wireless 
Benchmark SP 500  1,650   0.91  Index Moved Down -0.06% ...


Processing
Collecting data for EBN

Epicore quote and profile

 
 Companies |  Insiders  | Dashboard  
     
0.25
  
STOCK
0.00  No Change   0.00%  
May 25 2013 

Diversification Suggestion

Use Epicore to protect against small markets fluctuations. The stock experiences normal downward trend, but the immediate impact on correlations cannot be determined at the moment
Analyze Epicore BioNetworks Trend or Check current 30 days Epicore correlation with market (S&P 500)
1 Month Beta 1.35  
Highest Price:  
Lowest Price:  
0.28  
0.2  
May 06 2013 
April 26 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Epicore will likely underperform.
Epicore BioNetworks Inc Large BetaEpicore BioNetworks Beta Legend
EBN Canada TSXV #2623847CA
Epicore BioNetworks Inc
Industrial Goods
Pollution and Treatment Controls
Benchmark S&P 500
http://www.epicorebionetworks.com
Contact Number: 609. 267. 9118
Currency: CAD - Canadian Dollar
Traded on TSX Venture Exchange
    
Current Valuation3.9 M
Shares Outstanding24.56 M
Revenue5.48 M
EBITDA957.8 K
 Canada Canada   0.07 % Macroaxis: 0.07 Moved Up  
 
 thisGreen EBN EBN.V agains markets  0.00 % No Change  
 United States SP 500   0.06 % Macroaxis: 0.06 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Epicore Leadership

William Long CEO and President COO, Executive Director, Member of Audit Committee and Member of Compensation Committee
Philip Secretan Independent Chairman of the Board
Keith CMA CFO and Company Secretary
Russell Rosenzweig CFO and Company Secretary

Epicore Price and Market Media

The median price of Epicore for the period between Thu, Apr 25, 2013 and Sat, May 25, 2013 is 0.25 with a coefficient of variation of 13.14. The daily time series for the period is distributed with a sample standard deviation of 0.03, arithmetic mean of 0.25, and mean deviation of 0.03. The Stock did not receive any noticable media coverage during the period.
Epicore         SP 500
Price Growth (%)
 

Epicore Summary

Epicore BioNetworks Inc [EBN] is traded on TSX Venture Exchange in Canada. It is located in Eastampton, NJ and employs 8 people. The company currently falls under 'Nano-Cap' category with current market capitalization of 5.4 M. Epicore BioNetworks Inc classifies itself under Industrial Goods sector and is part of Pollution and Treatment Controls industry. This company has 24.56 M outstanding shares.
Epicore BioNetworks Inc. designs, develops, and manufactures biotechnology solutions and specialty animal feeds worldwide. more
Past Market
Over 30
Days
2
Out Of
100
 
Chance of
Less
Than
11 %
 
Follow Epicore with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Epicore to your reader
 

Epicore Research Report

Epicore vs. GLV Inc

Correlation analysis and fundamentals comparison between Epicore BioNetworks and GLV Inc

Epicore Executives

Keith CMA CFO and Company Secretary
Russell Rosenzweig CFO and Company Secretary
Keith Blackman CFO, Corporate Secretary

Epicore Directors

CHEM, FRSC Director, Member of Audit Committee and Member of Compensation Committee
Robert Poulton Independent Director, MBA
Fernando Abad Aquaculture Bus. Devel. Director
Fred Boulos Independent Director
Alan Savage Director

Epicore Fundamentals

One Year Low vs Number of Employees
Return On Asset vs Shares Outstanding
One Year Low vs Price to Earning
Current Valuation vs Shares Outstanding

Epicore vs Competition

Epicore vs. GLV Inc
Epicore vs. GLV Inc
Epicore vs. Alter NRG Corp
Epicore vs. BioteQ Environmental Technologies Inc
Epicore vs. Global Green Matrix Corp
Epicore vs. ProSep Inc

Epicore May 25 2013 Opportunity Range

Downside Deviation17.28
Information Ratio0.0283
Maximum Drawdown50.71
Value At Risk(10.71)
Potential Upside10.0

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium